Trial Profile
A phase 1 study to assess the effect of ABX 203 in patients with chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2015
Price :
$35
*
At a glance
- Drugs ABX 203 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Abivax
- 06 Jan 2015 New trial record